Cathie Wood (ARK Invest) bought RXRX via ARKK
ARK's ARKK bought 371,808 shares of Recursion Pharmaceuticals Inc (RXRX), representing 0.0208% of ETF, according to ARK's official daily trade file.
Signal
Investor Move
Action
Buy
Capital
$1.3M disclosed value
Why it matters
ARK publishes this official daily trade disclosure after execution, giving a more current view than quarterly 13F filings.